Mouse Models of Kidney Fibrosis.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 24 5 2021
pubmed: 25 5 2021
medline: 11 8 2021
Statut: ppublish

Résumé

Chronic kidney disease (CKD) affects over 10% of the worldwide population and kidney fibrosis is a main driver of CKD and considered a therapeutic target. The mechanisms leading to kidney fibrosis are highly complexed and can be best studied in rodent models. Here we describe the most commonly used kidney fibrosis models in mice, the unilateral ureteral obstruction (UUO) model and the ischemia reperfusion injury (IRI) model. Both models are easy to learn and can be applied in animals of different age, sex, and strain.

Identifiants

pubmed: 34028752
doi: 10.1007/978-1-0716-1382-5_22
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-338

Références

Kramann R, Machado F, Wu H, Kusaba T, Hoeft K, Schneider RK, Humphreys BD (2018) Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis. JCI Insight 3(9):e99561. https://doi.org/10.1172/jci.insight.99561
doi: 10.1172/jci.insight.99561 pmcid: 6012505
Kramann R, Wongboonsin J, Chang-Panesso M, Machado FG, Humphreys BD (2017) Gli1
doi: 10.1681/ASN.2016030297
Rabe M, Schaefer F (2016) Non-transgenic mouse models of kidney disease. Nephron 133(1):53–61. https://doi.org/10.1159/000445171
doi: 10.1159/000445171 pubmed: 27212380
Martínez-Klimova E, Aparicio-Trejo OE, Tapia E, Pedraza-Chaverri J (2019) Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments. Biomol Ther 9(4):141. https://doi.org/10.3390/biom9040141
doi: 10.3390/biom9040141
Heung M, Chawla LS (2014) Acute kidney injury: gateway to chronic kidney disease. Nephron Clin Pract 127(1–4):30–34. https://doi.org/10.1159/000363675
doi: 10.1159/000363675 pubmed: 25343817
Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. JCI (121):4210–4221
Hesketh EE, Czopek A, Clay M, Borthwick G, Ferenbach D, Kluth D, Hughes J (2014) Renal ischaemia reperfusion injury: a mouse model of injury and regeneration. J Vis Exp:88. https://doi.org/10.3791/51816
Kramann R, Fleig SV, Schneider RK, Fabian SL, DiRocco DP, Maarouf O, Wongboonsin J, Ikeda Y, Heckl D, Chang SL, Rennke HG, Waikar SS, Humphreys BD (2015) Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest 125(8):2935–2951. https://doi.org/10.1172/JCI74929
doi: 10.1172/JCI74929 pubmed: 26193634 pmcid: 4563736
Li L, Kang H, Zhang Q, D'Agati VD, Al-Awqati Q, Lin F (2019) FoxO3 activation in hypoxic tubules prevents chronic kidney disease. J Clin Invest 129(6):2374–2389. https://doi.org/10.1172/JCI122256
doi: 10.1172/JCI122256 pubmed: 30912765 pmcid: 6541430
Sauer M, Fleischmann T, Lipiski M, Arras M, Jirkof P (2016) Buprenorphine via drinking water and combined oral-injection protocols for pain relief in mice. Appl Anim Behav Sci 185:103–112. https://doi.org/10.1016/j.applanim.2016.09.009
doi: 10.1016/j.applanim.2016.09.009
Russell WMS, Burch RL (1959) The principles of humane experimental technique. Methuen, London, pp 69–154
Ham A, Kim M, Kim JY, Brown KM, Yeh J, D’Agati VD, Lee HT (2013) Critical role of interleukin-11 in isoflurane-mediated protection against ischemic acute kidney injury in mice. Anesthesiology 119(6):1389–1401. https://doi.org/10.1097/ALN.0b013e3182a950da
doi: 10.1097/ALN.0b013e3182a950da pubmed: 24037316
Aufhauser DD Jr, Wang Z, Murken DR, Bhatti TR, Wang Y, Ge G, Redfield RR 3rd, Abt PL, Wang L, Svoronos N, Thomasson A, Reese PP, Hancock WW, Levine MH (2016) Improved renal ischemia tolerance in females influences kidney transplantation outcomes. J Clin Invest 126(5):1968–1977. https://doi.org/10.1172/JCI84712
doi: 10.1172/JCI84712 pubmed: 27088798 pmcid: 4855926
Kuppe C, Ibrahim MM, Kranz J, Zhang X, Ziegler S, Perales-Patón J, Jansen J, Reimer KC, Smith JR, Dobie R, Wilson-Kanamori JR, Halder M, Xu Y, Kabgani N, Kaesler N, Klaus M, Gernhold L, Puelles VG, Huber TB, Boor P, Menzel S, Hoogenboezem RM, Bindels EMJ, Steffens J, Floege J, Schneider RK, Saez-Rodriguez J, Henderson NC, Kramann R. Decoding myofibroblast origins in human kidney fibrosis. Nature. 2021 Jan;589(7841):281–286. https://doi.org/10.1038/s41586-020-2941-1

Auteurs

Rafael Kramann (R)

Institute of Experimental Medicine and Systems Biology, RWTH Aachen University Hospital, Aachen, Germany. rkramann@gmx.net.
Department of Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands. rkramann@gmx.net.

Sylvia Menzel (S)

Institute of Experimental Medicine and Systems Biology, RWTH Aachen University Hospital, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH